Security reports

Honeywell operates across aerospace, building automation, industrial automation, and process solutions, providing hardware, software, and services for commercial buildings, manufacturing facilities, aviation systems, and energy infrastructure. The company develops technologies spanning building management systems, aviation components, industrial controls, warehouse automation, cybersecurity services, and sensing devices for healthcare and life sciences applications.

Amplitude provides a digital analytics platform that helps organizations analyze user behavior and optimize their products through tools including product analytics, web analytics, session replay, and experimentation features. The company offers solutions for testing, personalization, and customer engagement across the product development lifecycle.

NormShield provides third-party cyber risk management software that assesses and monitors the security posture of vendors and suppliers. The platform analyzes cyber risks across multiple categories including ransomware susceptibility, compliance gaps, and vulnerabilities, offering continuous monitoring and quantified financial impact assessments using the Open FAIR model.

CHS is a farmer-owned cooperative that provides agronomy products, grain marketing, food processing, and energy solutions including fuels and lubricants. The company serves agricultural producers and customers across multiple countries.

Docker provides a containerization platform that enables developers to build, share, and run applications in isolated container environments. The company offers Docker Desktop for local development, Docker Hub as a repository for container images, and Docker Hardened Images with enhanced security features and vulnerability reduction.

Catalyst Pharmaceuticals develops and commercializes therapies for rare diseases, with a focus on conditions such as Lambert-Eaton myasthenic syndrome (LEMS). The company operates in the biopharmaceutical sector, specializing in treatments for neuromuscular disorders.

Charles River Laboratories provides research models and preclinical services to pharmaceutical, biotechnology, and academic organizations. The company offers laboratory animal production, safety assessment testing, and contract research services to support drug discovery and development processes.

CRISPR Therapeutics develops gene-based medicines using CRISPR gene editing technology to treat serious diseases. The company focuses on therapeutic areas including hemoglobinopathies, oncology, autoimmune diseases, and regenerative medicine through both ex vivo and in vivo approaches.

Corindus Vascular Robotics develops robotic systems for precision vascular surgery and interventional procedures. The company's technology enables physicians to perform coronary and peripheral vascular interventions with enhanced control and accuracy from a radiation-shielded workstation.

Mylan was a pharmaceutical company that manufactured and distributed generic and branded medications across various therapeutic categories. The company merged with Pfizer's Upjohn division in 2020 to form Viatris, a global healthcare organization.

Perrigo Company plc manufactures and distributes over-the-counter healthcare products and consumer self-care solutions, including store-brand equivalents of allergy medications, pain relievers, digestive health products, and infant formula.

Asterias Biotherapeutics was a biotechnology company that focused on developing cell-based therapies for significant unmet medical needs. The company specialized in regenerative medicine applications, particularly involving embryonic stem cell-derived therapies for various conditions.

Advaxis is a biotechnology company that develops immunotherapies for the treatment of cancer and infectious diseases. The company's proprietary technology platform is based on live attenuated Listeria monocytogenes bacteria engineered to deliver tumor-associated antigens and stimulate immune responses.

Boston Scientific develops and manufactures medical devices and technologies used in interventional medical specialties. The company's products address conditions in cardiovascular, rhythm management, endoscopy, neuromodulation, and urology markets.

Agilent Technologies manufactures analytical laboratory instruments, software, and consumables for the life sciences, diagnostics, and applied chemical markets. The company provides solutions for research, testing, and analysis across pharmaceutical, biotechnology, clinical, environmental, and food safety applications.

Baxter International manufactures and distributes medical devices, pharmaceuticals, and biotechnology products for healthcare providers and patients. The company produces infusion pumps, injectable medications, clinical nutrition products, respiratory therapies, surgical care equipment, and connected healthcare technologies used across hospitals, physician offices, and home care settings.

The Cooper Companies operates as a global medical device manufacturer focused on vision care and women's health products. The company produces contact lenses, medical devices for fertility and gynecology, and surgical instruments through its primary business divisions.

AmerisourceBergen operates as a pharmaceutical distribution and services company that supplies medications and healthcare products to pharmacies, hospitals, physician practices, and veterinary facilities. The company provides wholesale distribution, specialty pharmaceutical services, manufacturer support solutions, and supply chain management across the healthcare sector.

Cyanotech cultivates and produces microalgae-based nutritional supplements at its facility in Hawaii. The company's primary products include BioAstin Hawaiian Astaxanthin and Hawaiian Spirulina, which are marketed for health and nutrition applications.

Cellectis is a clinical-stage biopharmaceutical company that develops allogeneic CAR T-cell immunotherapies for cancer treatment using its proprietary TALEN gene editing technology. The company creates off-the-shelf cellular therapies from healthy donor cells.

Atossa Genetics operates as a clinical-stage biopharmaceutical company focused on developing therapies for breast cancer and other breast health conditions. The company conducts research on therapeutic candidates and diagnostic technologies related to breast disease treatment and prevention.

FutureFuel provides custom toll manufacturing and specialty chemical synthesis services, producing organic chemicals for pharmaceutical, agricultural, coatings, and cleaning product applications. The company also manufactures biodiesel and markets performance chemicals under the FutureChem and FutureSol brands.

AGTC (now operating as Beacon Therapeutics) is a clinical-stage biotechnology company focused on developing gene therapies for ocular diseases. The company uses adeno-associated virus (AAV) gene therapy technology to treat rare and prevalent retinal conditions including X-linked retinitis pigmentosa, dry age-related macular degeneration, and cone rod dystrophy.

Zoetis develops and manufactures medicines, vaccines, diagnostics, and technologies for animal health across companion animals and livestock species. The company serves veterinarians, livestock producers, and pet owners in over 100 countries.

LyondellBasell manufactures chemicals, polymers, fuels, and advanced materials used in packaging, transportation, healthcare, and consumer goods applications. The company produces plastics, polymer solutions, and fuel ethers, and licenses chemical process technologies to the industry.

Pfizer is a biopharmaceutical company that discovers, develops, manufactures, and distributes prescription medicines and vaccines. The company focuses on therapeutic areas including oncology, internal medicine, inflammation and immunology, and rare diseases.

Cytori Therapeutics develops and manufactures medical devices focused on cell therapy and regenerative medicine applications. The company's technology processes adipose tissue to isolate and deliver cellular therapies for therapeutic use.

bluebird bio develops and commercializes gene therapies for rare genetic diseases. The company produces treatments for sickle cell disease, beta-thalassemia, and cerebral adrenoleukodystrophy using modified blood stem cells to address the underlying genetic causes of these conditions.

AMAG Pharmaceuticals was a specialty pharmaceutical company that focused on therapeutics for maternal health, anemia management, and other conditions. The company was acquired by Covis Pharma in 2020 and subsequently became part of Azurity Pharmaceuticals.

Acadia Pharmaceuticals develops and commercializes therapies for neurological disorders and rare diseases. The company focuses on conditions such as Parkinson's disease psychosis, Rett syndrome, and Alzheimer's disease psychosis.

Alexion develops and delivers therapeutic treatments for people living with rare diseases. The company focuses on research and development across multiple rare disease categories, including conditions affecting blood, cardiac, metabolic, and neurological systems.

Diplomat operates as an Icelandic business entity. Without available website content or additional public information, the specific nature of its products, services, or business operations cannot be determined.

AstraZeneca is a biopharmaceutical company that researches, develops, and manufactures prescription medicines across multiple therapy areas. The company's portfolio includes treatments for oncology, cardiovascular, renal, metabolic, and respiratory diseases.

DBV Technologies is a biopharmaceutical company focused on developing treatments for food allergies. The company's primary technology involves an epicutaneous immunotherapy platform that delivers allergen proteins through an adhesive patch applied to intact skin.

Dermira was a biopharmaceutical company focused on developing and commercializing therapies for dermatological conditions. The company specialized in treatments for medical dermatology, including hyperhidrosis and other skin disorders, before being acquired by Eli Lilly in 2020.

Celgene was a biopharmaceutical company that focused on developing and commercializing therapies for cancer and inflammatory diseases. The company was acquired by Bristol Myers Squibb in 2019 and now operates as part of that organization.

Aceto operates as a pharmaceutical and chemical company that sources, markets, and distributes finished dosage form generic drugs and active pharmaceutical ingredients. The company also provides specialty chemicals and intermediates for various industrial applications.

Waters manufactures and sells analytical instruments, software, and consumables for laboratory applications. The company provides liquid chromatography, mass spectrometry, and thermal analysis systems used in pharmaceutical development, food safety testing, and chemical research.

Cleveland BioLabs is a biopharmaceutical company that develops treatments for cancer and acute radiation syndrome. The company focuses on novel therapeutic approaches targeting radiation protection and oncology applications.

BiondVax operates as a clinical-stage biopharmaceutical company focused on developing universal influenza vaccines. The company's vaccine candidates are designed to provide protection against multiple strains of the flu virus through a single immunization.